pre-IPO PHARMA

COMPANY OVERVIEW

Amunix Pharmaceuticals, based in Mountain View, CA, is leveraging over a decade of expertise in precision protein engineering to enable the promise of T cell engagers and cytokines to treat patients with solid tumors. Our goal is to both develop and commercialize breakthrough therapies that harness the immune system.


LOCATION

  • Mountain View, CA, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://www.amunix.com


    CAREER WEBSITE

    https://www.amunix.com/careers/


    SOCIAL MEDIA


    INVESTORS

    frazier-healthcare


    PRESS RELEASES


    Dec 20, 2021

    Sanofi va acquérir Amunix pour son portefeuille en immuno-oncologie avec une nouvelle génération d’agents biologiques à activation conditionnelle


    Oct 7, 2021

    Amunix Presents Preclinical Data on Its XPAT T Cell Engager Platform at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics


    Jun 23, 2021

    Amunix Appoints Industry Veteran, Frank Watanabe, to its Board of Directors


    Apr 12, 2021

    Amunix Presents Preclinical Data at American Academy of Cancer Research (AACR) Annual Meeting from Lead Program AMX-818 Demonstrating Robust Efficacy in HER2 Tumor Models and Enhanced Safety


    Jan 26, 2021

    Amunix Announces the Appointment of Healthcare Investment Banking Veteran Zeeshan Merchant as Chief Financial Officer and Trisha Millican to the Board of Directors


    For More Press Releases


    Google Analytics Alternative